Editorial: Overcoming drug relapse and therapy resistance in NSCLC
Journal Title
Frontiers in Oncology
Publisher
Frontiers
Keywords
EGFR mutation; biomarkers; drug resistance; immunophenotyping; metabolism; non-small cell lung cancer; tumor microenvironment; tumor mutational burden (TMB)
Research Division(s)
Personalised Oncology
PubMed ID
37350939
Open Access at Publisher's Site
https://doi.org/10.3389/fonc.2023.1230475
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-06-30 02:16:16
Last Modified: 2023-06-30 02:59:49
An error has occurred. This application may no longer respond until reloaded. Reload 🗙